Kry vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Kry (Livi in UK/France) is Europe's leading digital primary care platform with $2B valuation; operates 60+ clinics; raised €516M total from Accel, Index Ventures, and Creandum;
About
Kry is a Swedish digital healthcare company founded in 2014 by Johannes Schildt and headquartered in Stockholm. It operates under the brand Kry in Sweden, Norway, and Germany, and as Livi in the UK and France. The company provides a hybrid primary care platform that combines on-demand video consultations — connecting patients with licensed physicians, nurses, and specialists within minutes through its app — with a network of 60+ physical primary care clinics where patients can book in-person appointments. This dual model enables Kry to serve the full spectrum of primary care needs, from acute digital triage to chronic disease management and preventive care.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.